227 related articles for article (PubMed ID: 34453393)
1. Perceptions regarding communicative participation in individuals receiving botulinum toxin injections for laryngeal dystonia.
Yorkston K; Baylor CR; Eadie T; Kapsner-Smith M
Int J Lang Commun Disord; 2021 Nov; 56(6):1296-1315. PubMed ID: 34453393
[TBL] [Abstract][Full Text] [Related]
2. Communicative participation outcomes in individuals with Parkinson's disease receiving standard care speech-language therapy services in community settings.
Baylor C; Linna Jin J; Mach H; Britton D
Int J Lang Commun Disord; 2024; 59(2):808-827. PubMed ID: 37855252
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Communicative Participation Item Bank as an Outcome Measure for Spasmodic Dysphonia.
Yiu Y; Baylor CR; Bamer AM; Shelly S; Klein AM; Garrett CG; Pitman MJ
Laryngoscope; 2021 Apr; 131(4):859-864. PubMed ID: 32710809
[TBL] [Abstract][Full Text] [Related]
4. Improved vocal quality and decreased vocal effort after botulinum toxin treatment for laryngeal dystonia.
Leung JS; Rosenbaum A; Holmberg J; Villarroel P; Napolitano C; Badía PI; Lagos-Villaseca A
Auris Nasus Larynx; 2024 Feb; 51(1):106-112. PubMed ID: 37365040
[TBL] [Abstract][Full Text] [Related]
5. Dutch translation and validation of the Communicative Participation Item Bank (CPIB)-short form.
van Sluis KE; Passchier E; van Son RJJH; van der Molen L; Stuiver M; van den Brekel MWM; Van den Steen L; Kalf JG; van Nuffelen G
Int J Lang Commun Disord; 2023 Jan; 58(1):124-137. PubMed ID: 36063423
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Self-Esteem, Coping, and Voice-Related Quality of Life on Communicative Participation Before and After BOTOX® Treatment for Spasmodic Dysphonia.
Engelhoven AER; Zraick RI; Bursac Z; Tulunay-Ugur O; Hadden K
J Voice; 2022 Jan; 36(1):146.e5-146.e16. PubMed ID: 32451253
[TBL] [Abstract][Full Text] [Related]
7. Association of Laryngeal Botulinum Neurotoxin Injection With Work Productivity for Patients With Spasmodic Dysphonia.
Meyer TK; Spiekerman C; Kaye R; Blitzer A; Kamizi RS; Jiang L; Weaver EM
JAMA Otolaryngol Head Neck Surg; 2021 Sep; 147(9):804-810. PubMed ID: 34351425
[TBL] [Abstract][Full Text] [Related]
8. Validating the Communicative Participation Item Bank (CPIB) for use with people with aphasia: an analysis of Differential Item Function (DIF).
Baylor C; Oelke M; Bamer A; Hunsaker E; Off C; Wallace SE; Pennington S; Kendall D; Yorkston K
Aphasiology; 2017; 31(8):861-878. PubMed ID: 30918415
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Psychosocial Impact of Botulinum Toxin Type A Injections for Individuals With Oromandibular Dystonia: A Qualitative Study of Patients' Experiences.
Page AD; Elhayek N; Baylor C; Adams S; Jog M; Yorkston K
Am J Speech Lang Pathol; 2021 Jun; 30(3S):1314-1328. PubMed ID: 33647215
[TBL] [Abstract][Full Text] [Related]
10. Quantitative laryngeal electromyography parameters may correlate with improved outcomes following botulinum toxin injection for spasmodic dysphonia.
Dwyer CD; Leclerc AA; Nandedkar SD; Young VN; Rosen CA
Muscle Nerve; 2021 Apr; 63(4):525-530. PubMed ID: 33382480
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Patients Receiving Short-Interval Botulinum Toxin Chemodenervation Treatment for Laryngeal Dystonia and Essential Tremor of the Vocal Tract.
Lagos-Villaseca A; Bhatt NK; Abdolhosseini P; Quinonez L; Paoletti MF; Gochman G; Johns MM; Rosen CA; Kao TC; Meyer TK
JAMA Otolaryngol Head Neck Surg; 2023 Jul; 149(7):615-620. PubMed ID: 37227721
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of the Communicative Participation Item Bank for Measuring Patient-Reported Outcomes After Treatment of Unilateral Vocal Fold Immobility.
Baylor C; Merati AL; Eadie T; Kapsner-Smith M; Meyer TK; Britton D; Mach H; Patel S; Yorkston K
JAMA Otolaryngol Head Neck Surg; 2021 Nov; 147(11):933-942. PubMed ID: 34529046
[TBL] [Abstract][Full Text] [Related]
13. Further development in measuring communicative participation: identifying items to extend the applicability of the communicative participation item bank.
Ter Wal N; van Ewijk L; Visser-Meily JMA; Volkmer A; Gerrits E; Terwee CB
J Patient Rep Outcomes; 2023 May; 7(1):49. PubMed ID: 37237158
[TBL] [Abstract][Full Text] [Related]
14. Modifying the Communicative Participation Item Bank (CPIB) for individuals receiving gender-affirming communication care: Stakeholder feedback from cognitive interviews.
Teixeira J; Jin JL; Baylor C; Nuara M
J Commun Disord; 2023; 102():106312. PubMed ID: 36791644
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia.
Benninger MS; Gardner G; Grywalski C
Arch Otolaryngol Head Neck Surg; 2001 Sep; 127(9):1083-5. PubMed ID: 11556856
[TBL] [Abstract][Full Text] [Related]
16. Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia.
Yeung W; Richards AL; Novakovic D
Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548741
[TBL] [Abstract][Full Text] [Related]
17. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
Loven JO; Brøndbo K; Ganes T
Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289
[TBL] [Abstract][Full Text] [Related]
18. Intensive Voice Treatment following Botulinum Neurotoxin Injection for a Speaker with Abductor Laryngeal Dystonia: An Exploratory Case Study.
Schnell M; Slavin D
Semin Speech Lang; 2024 Mar; 45(2):137-151. PubMed ID: 38417816
[TBL] [Abstract][Full Text] [Related]
19. The Communicative Participation Item Bank (CPIB): item bank calibration and development of a disorder-generic short form.
Baylor C; Yorkston K; Eadie T; Kim J; Chung H; Amtmann D
J Speech Lang Hear Res; 2013 Aug; 56(4):1190-208. PubMed ID: 23816661
[TBL] [Abstract][Full Text] [Related]
20. The Communicative Participation Item Bank: Evaluating, and Reevaluating, Its Use across Communication Disorders in Adults.
Baylor C; Eadie T; Yorkston K
Semin Speech Lang; 2021 Jun; 42(3):225-239. PubMed ID: 34261165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
